The acute assessment of MRgFUS therapies with metrics such as thermal dose and contrast-enhanced (CE) imaging have been shown to under- or over-estimate the final ablation lesion as assessed by delayed imaging or histological outcomes. The aim of this study is to longitudinally register MRgFUS treatment images to a final lesion outcome as determined by CE-T1w imaging three days post-treatment for voxel-wise analysis of these errors. MR thermometry (MRTI), cumulative thermal dose (CTD), and acute CE-T1w images are co-registered to Day 3 CE-T1w with millimeter accuracy and assessed for their predictive value.
How to access this content:
For one year after publication, abstracts and videos are only open to registrants of this annual meeting. Registrants should use their existing login information. Non-registrant access can be purchased via the ISMRM E-Library.
After one year, current ISMRM & ISMRT members get free access to both the abstracts and videos. Non-members and non-registrants must purchase access via the ISMRM E-Library.
After two years, the meeting proceedings (abstracts) are opened to the public and require no login information. Videos remain behind password for access by members, registrants and E-Library customers.
Keywords